Click Here to
receive daily
reports of the
TOP PICKS
OR
your personal
stock choices

STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 3 registered members and 66 guests viewing the site. Follow us on Twitter Rss Top Picks FeedRss Daily Feed
David King of Putnam Investments

Opinions from David King

BUYAbbott LabsABT-N44.020Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.2004-04-30
TOP PICKFannie MaeFNMA-Q268.710A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.2004-04-30
BUYKing PharmaceuticalsKG-N (Dead)17.250A potential takeover play. Has been a bit undermanaged and is very cheap.2004-04-30
TOP PICKXeroxXRX-N13.430Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.2004-04-30

Privacy Policy